.After antibody-drug conjugate (ADC) expert Seagen was offered to Pfizer in 2013 for an enormous $43...
.On the heels of a stage 3 gain that neglected to excite investors, Ironwood Pharmaceuticals is actu...
.Don't cease Monte Rosa Therapeutics now. The Boston-based biotech is enjoying after authorizing a m...
.Invite to this week's Chutes & Ladders, our summary of considerable leadership hirings, shooting...
.Commemorating his provider's upsized going public (IPO), Septerna CEO Jeffrey Finer sounded the pos...
.AbbVie has actually gone back to the resource of its antipsychotic goliath Vraylar looking for anot...
.GenSight Biologics is full weeks far from lacking loan. Again. The biotech simply has enough cash t...
.Monopar Therapeutics is actually recouping a drug from the dump of AstraZeneca's unusual condition ...
.Along with brand-new data out on Arcus Biosciences' experimental HIF-2a inhibitor, one group of ana...
.After creating a gene treatment alliance along with Dyno Therapies in 2020, Roche is actually back ...